Show simple item record

dc.contributor.authorKocak, H
dc.contributor.authorOner-Iyidogan, Y
dc.contributor.authorKocak, Taner
dc.contributor.authorOner, P
dc.date.accessioned2021-03-05T22:00:29Z
dc.date.available2021-03-05T22:00:29Z
dc.date.issued2004
dc.identifier.citationKocak H., Oner-Iyidogan Y., Kocak T., Oner P., "Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer", CLINICAL BIOCHEMISTRY, cilt.37, ss.673-678, 2004
dc.identifier.issn0009-9120
dc.identifier.otherav_db8b0b96-13a2-4e3e-8734-905a76702017
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/144722
dc.identifier.urihttps://doi.org/10.1016/j.clinbiochem.2004.02.005
dc.description.abstractObjectives: This study was planned to evaluate the feasibility of the assay of leukocyte arylsulfatase-A (AS-A) activity, and some urinary cytokine levels (tumor necrosis factor-alpha [TNF-alpha] and interleukin-8 [IL-8]), as noninvasive diagnostic tools in different stages of bladder cancer patients.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleDetermination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer
dc.typeMakale
dc.relation.journalCLINICAL BIOCHEMISTRY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume37
dc.identifier.issue8
dc.identifier.startpage673
dc.identifier.endpage678
dc.contributor.firstauthorID22040


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record